Can Small Chemical Modifications Of Natural Pan-Inhibitors Modulate The Biological Selectivity? The Case Of Curcumin Prenylated Derivatives Acting As Hdac Or Mpges-1 Inhibitors

Curcumin, or diferuloylmethane, a polyphenolic molecule isolated from the rhizome of Curcuma Longa, is reported to modulate multiple molecular targets involved in cancer and inflammatory processes. On the basis of its pan-inhibitory characteristics, here we show that simple chemical modifications of the curcumin scaffold can regulate its biological selectivity. In particular, the curcumin scaffold was modified with three types of substituents at positions C-1, C-8, and/or C-8' [C-5 (isopentenyl, 5-8), C-10 (geranyl, 9-12), and C-15 (farnesyl, 13, 14)] in order to make these molecules more selective than the parent compound toward two specific targets: histone deacetylase (HDAC) and microsomal prostaglandin E-2 synthase-1 (mPGES-1). From combined in silico and in vitro analyses, three selective inhibitors by proper substitution at position 8 were revealed. Compound 13 has improved HDAC inhibitory activity and selectivity with respect to the parent compound, while 5 and 9 block the mPGES-1 enzyme. We hypothesize about the covalent interaction of curcumin, 5, and 9 with the mPGES-1 binding site.